Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BARNWELL INDUSTRIES INCBRN · Entity 7823 | Director | December 03, 2025 | December 04, 2025 |
| BED BATH & BEYOND INCBBBY · Entity 117013 | Director | January 20, 2023 | January 27, 2023 |
| GENESCO INCGCO · Entity 5742 | Director | June 27, 2018 | June 28, 2018 |
| LIFECORE BIOMEDICAL, INC. \DE\LFCR · Entity 6447 | Director | June 04, 2026 | June 05, 2026 |
| Pursuit Attractions & Hospitality, Inc.PRSU · Entity 4779 | Director | March 01, 2026 | March 03, 2026 |
| Sunworks, Inc.SUNW · Entity 95102 | Director | August 15, 2019 | August 19, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BARNWELL INDUSTRIES INC
Report date December 03, 2025 · Filed December 04, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 83,674 |
Reported balance
After 2025-12-03 transaction · row 1
1 source rowRow 1 · 2025-12-03 · Grant · Acquired 43,860 · Balance 83,674 F1: Represents a restricted stock unit award to a non-employee director made pursuant to a grant by the Board of Directors of Barnwell Industries, Inc. on December 3, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a restricted stock unit award to a non-employee director made pursuant to a grant by the Board of Directors of Barnwell Industries, Inc. on December 3, 2025.
BED BATH & BEYOND INC
Report date January 20, 2023 · Filed January 27, 2023 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $.01 par value per shareSEC Table I · non-derivative | Direct | 77,128 |
Reported balance
After 2023-01-20 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2023-01-20 · Disposition to issuer · Disposed 0 · Balance 77,128 F1: This amendment is being filed to reflect the cancellation of the transactions previously reported by the Reporting Person in the Form 4 filed on January 24, 2023. As a result, the reported restricted stock awards remain held by the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: This amendment is being filed to reflect the cancellation of the transactions previously reported by the Reporting Person in the Form 4 filed on January 24, 2023. As a result, the reported restricted stock awards remain held by the Reporting Person.
GENESCO INC
Report date June 27, 2018 · Filed June 28, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,489 |
Reported balance
After 2018-06-27 transaction · row 1
1 source rowRow 1 · 2018-06-27 · Grant · Acquired 2,489 · Balance 2,489 F1: Grant of restricted stock under Second Amended and Restated 2009 Equity Incentive Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of restricted stock under Second Amended and Restated 2009 Equity Incentive Plan.
LIFECORE BIOMEDICAL, INC. \DE\
Report date June 04, 2026 · Filed June 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 133,080 |
Reported balance
After 2026-06-04 transaction · row 1
1 source rowRow 1 · 2026-06-04 · Grant · Acquired 25,907 · Balance 133,080 F1: The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis. F2: Vests on earlier of June 4, 2027 or the date of the annual meeting of stockholders of the Company first held in calendar year 2027 (provided such date is no less than 50 weeks from June 4, 2026). |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.
F2: Vests on earlier of June 4, 2027 or the date of the annual meeting of stockholders of the Company first held in calendar year 2027 (provided such date is no less than 50 weeks from June 4, 2026).
Pursuit Attractions & Hospitality, Inc.
Report date March 01, 2026 · Filed March 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 60,444 |
Reported balance
After 2026-03-01 transaction · row 1
1 source rowRow 1 · 2026-03-01 · Grant · Acquired 3,596 · Balance 60,444 F1: Restricted Stock Units granted on March 1, 2026, pursuant to the 2017 Pursuit Attractions and Hospitality, Inc. Omnibus Incentive Plan, and will vest one year from the date of grant and are payable in shares of the Issuer's common stock on a one-for-one basis upon vesting. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted Stock Units granted on March 1, 2026, pursuant to the 2017 Pursuit Attractions and Hospitality, Inc. Omnibus Incentive Plan, and will vest one year from the date of grant and are payable in shares of the Issuer's common stock on a one-for-one basis upon vesting.
Sunworks, Inc.
Report date August 15, 2019 · Filed August 19, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.44 · Expires 2024-08-01 | Direct | 25,000 |
Reported balance
After 2019-08-15 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-08-15 · Grant · Acquired 25,000 · Balance 25,000 F1: The Option was issued pursuant to the Company's 2016 Equity Incentive Plan and shall vest and become exercisable in 1/12 increments over a one-year period commencing on 09/01/2019. |
Filing footnotes · ownership attribution and instrument terms
F1: The Option was issued pursuant to the Company's 2016 Equity Incentive Plan and shall vest and become exercisable in 1/12 increments over a one-year period commencing on 09/01/2019.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Support.com, Inc.
Report date September 14, 2021 · Filed September 15, 2021
Section 16 reporting ended · disclosed 2021-09-15. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-09-14 transaction · row 1
1 source rowRow 1 · 2021-09-14 · Disposition to issuer · Disposed 177,203 · Balance 0 F1: Support.com, Inc., a Delaware corporation (the "Company"), entered into an Agreement and Plan of Merger (the "Merger Agreement"), dated as of March 19, 2021, by and among the Company, Greenidge Generation Holdings Inc., a Delaware corporation ("Greenidge") and GGH Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Greenidge ("Merger Sub"). On September 14, 2021, Merger Sub merged with and into the Company, the separate corporate existence of Merger Sub ceased and the Company survived the merger as a direct wholly owned subsidiary of Greenidge. F2: (Continued from Footnote 1) Pursuant to the terms of the Merger Agreement, each share of common stock, par value $0.0001 per share, of the Company (the "Common Stock") and each restricted stock unit of the Company that was outstanding as of the closing of the merger (the "Closing") was converted into the right to receive 0.115 shares of class A common stock, par value $0.0001 per share, of Greenidge (the "Greenidge Class A Common Stock") (the "Exchange Ratio"). F3: Represents 151,823 shares of Common Stock and 25,380 restricted stock units held by the Reporting Person. In connection with the Closing, each share of Common Stock and each restricted stock unit held by the Reporting Person as of the Closing was converted into the right to receive 0.115 shares of Greenidge Class A Common Stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Support.com, Inc., a Delaware corporation (the "Company"), entered into an Agreement and Plan of Merger (the "Merger Agreement"), dated as of March 19, 2021, by and among the Company, Greenidge Generation Holdings Inc., a Delaware corporation ("Greenidge") and GGH Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Greenidge ("Merger Sub"). On September 14, 2021, Merger Sub merged with and into the Company, the separate corporate existence of Merger Sub ceased and the Company survived the merger as a direct wholly owned subsidiary of Greenidge.
F2: (Continued from Footnote 1) Pursuant to the terms of the Merger Agreement, each share of common stock, par value $0.0001 per share, of the Company (the "Common Stock") and each restricted stock unit of the Company that was outstanding as of the closing of the merger (the "Closing") was converted into the right to receive 0.115 shares of class A common stock, par value $0.0001 per share, of Greenidge (the "Greenidge Class A Common Stock") (the "Exchange Ratio").
F3: Represents 151,823 shares of Common Stock and 25,380 restricted stock units held by the Reporting Person. In connection with the Closing, each share of Common Stock and each restricted stock unit held by the Reporting Person as of the Closing was converted into the right to receive 0.115 shares of Greenidge Class A Common Stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 04, 2026 Filed Jun 5, 2026 20:46 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LFCR · Entity 6447 | GrantCommon Stock | 25,907 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001336601-26-000004 · wk-form4_1780692374.xml · nonDerivative · entry 1 Schechter Joshua · CIK 0001336601 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,080 F1 · price: The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis. F2 · price: Vests on earlier of June 4, 2027 or the date of the annual meeting of stockholders of the Company first held in calendar year 2027 (provided such date is no less than 50 weeks from June 4, 2026). Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 22:15 UTC | Pursuit Attractions & Hospitality, Inc. PRSU · Entity 4779 | GrantCommon Stock | 3,596 | $0.00 | $0.00 |
DisclosureSEC source: 0001336601-26-000002 · form4-03032026_050305.xml · nonDerivative · entry 1 Schechter Joshua · CIK 0001336601 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,444 F1 · shares: Restricted Stock Units granted on March 1, 2026, pursuant to the 2017 Pursuit Attractions and Hospitality, Inc. Omnibus Incentive Plan, and will vest one year from the date of grant and are payable in shares of the Issuer's common stock on a one-for-one basis upon vesting. Read SEC document |
| December 03, 2025 Filed Dec 4, 2025 21:41 UTC | BARNWELL INDUSTRIES INC BRN · Entity 7823 | GrantCommon Stock | 43,860 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-25-000711 · form4.xml · nonDerivative · entry 1 Schechter Joshua · CIK 0001336601 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,674 F1 · price: Represents a restricted stock unit award to a non-employee director made pursuant to a grant by the Board of Directors of Barnwell Industries, Inc. on December 3, 2025. Read SEC document |
| November 10, 2025 Filed Nov 12, 2025 21:15 UTC | Pursuit Attractions & Hospitality, Inc. PRSU · Entity 4779 | PurchaseCommon Stock | 1,000 | $34.00 | $34,000.00 |
DisclosureSEC source: 0001336601-25-000006 · form4-11122025_041107.xml · nonDerivative · entry 1 Schechter Joshua · CIK 0001336601 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,848 Read SEC document |
| July 15, 2025 Filed Jul 17, 2025 20:39 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LFCR · Entity 6447 | GrantCommon Stock | 19,506 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001005286-25-000088 · wk-form4_1752784730.xml · nonDerivative · entry 1 Schechter Joshua · CIK 0001336601 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,173 F1 · price: The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis. F2 · price: Vests on the earlier of the one year anniversary of the date hereof or the date of the annual meeting of stockholders of the Company first held in calendar year 2026 (provided such date is no less than 50 weeks from the date hereof). Read SEC document |
| March 01, 2025 Filed Mar 5, 2025 00:40 UTC | Pursuit Attractions & Hospitality, Inc. PRSU · Entity 4779 | GrantCommon Stock | 3,149 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-006774 · form4-03042025_070308.xml · nonDerivative · entry 1 Schechter Joshua · CIK 0001336601 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,848 F1 · shares: Restricted Stock Units granted on March 1, 2025, pursuant to the 2017 Pursuit Attractions and Hospitality, Inc. Omnibus Incentive Plan, and will vest one year from the date of grant and are payable in shares of the Issuer's common stock on a one-for-one basis upon vesting. Read SEC document |
| July 08, 2024 Filed Jul 10, 2024 23:41 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LFCR · Entity 6447 | GrantCommon Stock | 30,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-24-031624 · wk-form4_1720654875.xml · nonDerivative · entry 1 Schechter Joshua · CIK 0001336601 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,667 F1 · price: The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis. F2 · price: Vests on earlier of the first anniversary of the grant date or the date of the annual meeting of stockholders first held in calendar year 2025, subject to potential acceleration. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 20:00 UTC | Pursuit Attractions & Hospitality, Inc. VVI · Entity 4779 | GrantCommon Stock | 3,376 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-004310 · doc4.xml · nonDerivative · entry 1 Schechter Joshua · CIK 0001336601 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,699 F1 · shares: Restricted Stock Units granted on March 1, 2024, pursuant to the Amended & Restated 2017 Viad Corp Omnibus Incentive Plan, and will vest one year from the date of grant and are payable in shares of VVI common stock on a one-for-one basis upon vesting. Read SEC document |
| March 01, 2024 Filed Aug 7, 2024 20:00 UTC Amendment | Pursuit Attractions & Hospitality, Inc. VVI · Entity 4779 | GrantCommon Stock | 3,376 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-005955 · doc4a.xml · nonDerivative · entry 1 Schechter Joshua · CIK 0001336601 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,699 F1 · shares: Restricted Stock Units granted on March 1, 2024, pursuant to the Amended & Restated 2017 Viad Corp Omnibus Incentive Plan, and will vest one year from the date of grant and are payable in shares of VVI common stock on a one-for-one basis upon vesting. F2 · balance_after: This Form 4/A is being filed to correct an inadvertent administrative error in the original Form 4 regarding the amount of shares of common stock beneficially owned following the reported transaction. Read SEC document |
| February 01, 2024 Filed Feb 3, 2024 00:02 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LFCR · Entity 6447 | Exercise / conversionRestricted Stock Units · Derivative | 9,554 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-003144 · wk-form4_1706918511.xml · derivative · entry 3 Schechter Joshua · CIK 0001336601 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,554 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis. F2 · derivative.expiration_date: The restricted stock units vested on February 1, 2024. Read SEC document |
| February 01, 2024 Filed Feb 3, 2024 00:02 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LFCR · Entity 6447 | Exercise / conversionCommon Stock | 9,554 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-24-003144 · wk-form4_1706918511.xml · nonDerivative · entry 1 Schechter Joshua · CIK 0001336601 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,667 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 19:02 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LFCR · Entity 6447 | GrantCommon Stock | 18,182 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-020822 · wk-form4_1685991739.xml · nonDerivative · entry 1 Schechter Joshua · CIK 0001336601 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,113 F1 · price: The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis. F2 · price: Restricted Stock Units will vest and be settled on the earlier of the 1st anniversary of the grant date or the date of the 2024 Annual Meeting of Stockholders (provided such date is no less than 50 weeks from Grant Date). Read SEC document |
| May 31, 2023 Filed Jun 1, 2023 22:37 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LFCR · Entity 6447 | Exercise / conversionRestricted Stock Unit · Derivative | 9,474 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-020573 · wk-form4_1685659029.xml · derivative · entry 3 Schechter Joshua · CIK 0001336601 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,474 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis. F2 · derivative.exercise_date: The restricted stock units vested on May 31, 2023. F2 · derivative.expiration_date: The restricted stock units vested on May 31, 2023. Read SEC document |
| May 31, 2023 Filed Jun 1, 2023 22:37 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LFCR · Entity 6447 | Exercise / conversionCommon Stock | 9,474 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-020573 · wk-form4_1685659029.xml · nonDerivative · entry 1 Schechter Joshua · CIK 0001336601 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,931 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis. F2 · price: The restricted stock units vested on May 31, 2023. Read SEC document |
| May 09, 2023 Filed May 11, 2023 20:24 UTC | Pursuit Attractions & Hospitality, Inc. VVI · Entity 4779 | PurchaseCommon Stock | 1,000 | $21.80 | $21,800.50 |
DisclosureSEC source: 0001209191-23-028752 · doc4.xml · nonDerivative · entry 2 Schechter Joshua · CIK 0001336601 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,323 Read SEC document |
| May 09, 2023 Filed May 11, 2023 20:24 UTC | Pursuit Attractions & Hospitality, Inc. VVI · Entity 4779 | PurchaseCommon Stock | 1,000 | $21.89 | $21,890.10 |
DisclosureSEC source: 0001209191-23-028752 · doc4.xml · nonDerivative · entry 1 Schechter Joshua · CIK 0001336601 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,323 Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:01 UTC | Pursuit Attractions & Hospitality, Inc. VVI · Entity 4779 | GrantCommon Stock | 4,980 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-015383 · doc4.xml · nonDerivative · entry 1 Schechter Joshua · CIK 0001336601 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,323 F1 · shares: Restricted Stock Units granted on March 1, 2023, pursuant to the Amended & Restated 2017 Viad Corp Omnibus Incentive Plan, and will vest one year from the date of grant and are payable in shares of VVI common stock on a one-for-one basis upon vesting. Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 22:30 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LFCR · Entity 6447 | GrantRestricted Stock Unit · Derivative | 9,554 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-002096 · wf-form4_167537698735747.xml · derivative · entry 1 Schechter Joshua · CIK 0001336601 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,554 Underlying: Common Stock · 9,554 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis. F1 · price: The Restricted Stock Units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis. F2 · derivative.expiration_date: Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock. Read SEC document |
| January 20, 2023 Filed Jan 24, 2023 16:39 UTC | BED BATH & BEYOND INC BBBY · Entity 117013 | Disposition to issuerCommon Stock, $.01 par value per share | 42,041 | $0.00 | $0.00 |
DisclosureSEC source: 0000886158-23-000018 · wf-form4_167459632458808.xml · nonDerivative · entry 1 Schechter Joshua · CIK 0001336601 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,087 F1 · shares: Represents 42,041 restricted stock awards ("RSAs") that were cancelled in exchange for a cash payment equal to $206,000. Read SEC document |
| January 20, 2023 Filed Jan 27, 2023 07:26 UTC Amendment | BED BATH & BEYOND INC BBBY · Entity 117013 | Disposition to issuerCommon Stock, $.01 par value per share | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0000886158-23-000040 · wf-form4a_167482235148972.xml · nonDerivative · entry 1 Schechter Joshua · CIK 0001336601 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,128 F1 · shares: This amendment is being filed to reflect the cancellation of the transactions previously reported by the Reporting Person in the Form 4 filed on January 24, 2023. As a result, the reported restricted stock awards remain held by the Reporting Person. F1 · price: This amendment is being filed to reflect the cancellation of the transactions previously reported by the Reporting Person in the Form 4 filed on January 24, 2023. As a result, the reported restricted stock awards remain held by the Reporting Person. F1 · balance_after: This amendment is being filed to reflect the cancellation of the transactions previously reported by the Reporting Person in the Form 4 filed on January 24, 2023. As a result, the reported restricted stock awards remain held by the Reporting Person. Read SEC document |
| July 14, 2022 Filed Jul 15, 2022 16:57 UTC | BED BATH & BEYOND INC BBBY · Entity 117013 | GrantCommon Stock, $.01 par value per share | 42,041 | $0.00 | $0.00 |
DisclosureSEC source: 0000886158-22-000136 · wf-form4_165791864437546.xml · nonDerivative · entry 1 Schechter Joshua · CIK 0001336601 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,128 F1 · shares: Represents a grant of restricted stock under the Issuer's 2018 Incentive Compensation Plan issued as part of the Issuer's annual director compensation program. The restricted stock will vest on the earlier of July 14, 2023 or the Issuer's 2023 Annual Meeting of Shareholders. Read SEC document |
| June 04, 2022 Filed Jun 7, 2022 21:17 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRestricted Stock Unit · Derivative | 7,059 | $9.50 | $67,060.50 |
DisclosureSEC source: 0001628280-22-016487 · wf-form4_165463662087159.xml · derivative · entry 3 Schechter Joshua · CIK 0001336601 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,059 shares Expires 2022-06-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · shares: The restricted stock units were granted on June 4, 2021. F3 · derivative.exercise_date: The restricted stock units vested on June 4, 2022. F3 · derivative.expiration_date: The restricted stock units vested on June 4, 2022. Read SEC document |
| June 04, 2022 Filed Jun 7, 2022 21:17 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantCommon Stock | 7,059 | $9.50 | $67,060.50 |
DisclosureSEC source: 0001628280-22-016487 · wf-form4_165463662087159.xml · nonDerivative · entry 1 Schechter Joshua · CIK 0001336601 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,457 F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
| May 31, 2022 Filed Jun 2, 2022 16:37 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantRestricted Stock Unit · Derivative | 9,474 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-22-015995 · wf-form4_165418785156229.xml · derivative · entry 1 Schechter Joshua · CIK 0001336601 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,474 Underlying: Common Stock · 9,474 shares Expires not disclosed F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · derivative.expiration_date: Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 19:20 UTC | Pursuit Attractions & Hospitality, Inc. VVI · Entity 4779 | GrantCommon Stock | 3,681 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-013044 · doc4.xml · nonDerivative · entry 1 Schechter Joshua · CIK 0001336601 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,343 F1 · shares: Restricted Stock Units ("RSUs") granted on February 23, 2022, pursuant to the 2017 Viad Corp Omnibus Incentive Plan, will vest one year from the date of grant, generally subject to continued service as a Director through the vesting date. Each RSU represents a contingent right to receive one share of Common Stock. Read SEC document |
| January 12, 2022 Filed Jan 14, 2022 19:22 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | PurchaseCommon Stock | 2,000 | $10.41 | $20,820.00 |
DisclosureSEC source: 0001593968-22-000214 · primary_01.xml · nonDerivative · entry 2 Schechter Joshua · CIK 0001336601 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 2,000 Read SEC document |
| January 12, 2022 Filed Jan 14, 2022 19:22 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | PurchaseCommon Stock | 8,000 | $10.39 | $83,120.00 |
DisclosureSEC source: 0001593968-22-000214 · primary_01.xml · nonDerivative · entry 1 Schechter Joshua · CIK 0001336601 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,398 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $10.35 to $10.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| January 07, 2022 Filed Jan 11, 2022 16:15 UTC | BED BATH & BEYOND INC BBBY · Entity 117013 | PurchaseCommon Stock, $.01 par value per share | 6,000 | $13.86 | $83,160.00 |
DisclosureSEC source: 0000886158-22-000011 · wf-form4_164193573382339.xml · nonDerivative · entry 1 Schechter Joshua · CIK 0001336601 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,087 F1 · price: The price reported in Column 4 ($13.86) is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $13.85 to $13.87, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1). Read SEC document |
| October 14, 2021 Filed Oct 18, 2021 16:22 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRestricted Stock Unit · Derivative | 5,398 | $9.77 | $52,738.46 |
DisclosureSEC source: 0001593968-21-002277 · primary_01.xml · derivative · entry 2 Schechter Joshua · CIK 0001336601 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,398 shares Expires 2021-10-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · shares: The restricted stock units were granted on October 14, 2020. F3 · derivative.exercise_date: The restricted stock units vested on October 14, 2021. F3 · derivative.expiration_date: The restricted stock units vested on October 14, 2021. Read SEC document |
| October 14, 2021 Filed Oct 18, 2021 16:22 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantCommon Stock | 5,398 | $9.77 | $52,738.46 |
DisclosureSEC source: 0001593968-21-002277 · primary_01.xml · nonDerivative · entry 1 Schechter Joshua · CIK 0001336601 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,398 F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
| September 14, 2021 Filed Sep 15, 2021 18:24 UTC | Support.com, Inc. SPRT · Entity 135472 | Disposition to issuerCommon Stock | 177,203 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-036147 · doc4.xml · nonDerivative · entry 1 Schechter Joshua · CIK 0001336601 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Support.com, Inc., a Delaware corporation (the "Company"), entered into an Agreement and Plan of Merger (the "Merger Agreement"), dated as of March 19, 2021, by and among the Company, Greenidge Generation Holdings Inc., a Delaware corporation ("Greenidge") and GGH Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Greenidge ("Merger Sub"). On September 14, 2021, Merger Sub merged with and into the Company, the separate corporate existence of Merger Sub ceased and the Company survived the merger as a direct wholly owned subsidiary of Greenidge. F2 · kind: (Continued from Footnote 1) Pursuant to the terms of the Merger Agreement, each share of common stock, par value $0.0001 per share, of the Company (the "Common Stock") and each restricted stock unit of the Company that was outstanding as of the closing of the merger (the "Closing") was converted into the right to receive 0.115 shares of class A common stock, par value $0.0001 per share, of Greenidge (the "Greenidge Class A Common Stock") (the "Exchange Ratio"). F3 · shares: Represents 151,823 shares of Common Stock and 25,380 restricted stock units held by the Reporting Person. In connection with the Closing, each share of Common Stock and each restricted stock unit held by the Reporting Person as of the Closing was converted into the right to receive 0.115 shares of Greenidge Class A Common Stock. F3 · price: Represents 151,823 shares of Common Stock and 25,380 restricted stock units held by the Reporting Person. In connection with the Closing, each share of Common Stock and each restricted stock unit held by the Reporting Person as of the Closing was converted into the right to receive 0.115 shares of Greenidge Class A Common Stock. Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 16:46 UTC | BED BATH & BEYOND INC BBBY · Entity 117013 | GrantCommon Stock, $.01 par value per share | 5,071 | $0.00 | $0.00 |
DisclosureSEC source: 0001387131-21-006788 · schechter-form4_061721.xml · nonDerivative · entry 1 Schechter Joshua · CIK 0001336601 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,087 F1 · shares: Represents a grant of restricted stock under the Issuer's 2012 Incentive Compensation Plan valued at $150,000, issued as part of annual director compensation and approved by the Board of Directors of the Issuer on June 17, 2021. The number of shares was determined based on a stock price of $29.58, the average of the high and low trading prices of the Issuer's common stock on June 17, 2021. The restricted stock will vest on February 26, 2022, the last day of the fiscal year of grant, provided that the director remains in office until the last day of the fiscal year. Read SEC document |
| June 04, 2021 Filed Jun 9, 2021 00:02 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantRestricted Stock Unit · Derivative | 7,059 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001593968-21-001571 · primary_01.xml · derivative · entry 1 Schechter Joshua · CIK 0001336601 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,059 Underlying: Common Stock · 7,059 shares Expires not disclosed F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · derivative.expiration_date: Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock. Read SEC document |
| April 16, 2021 Filed Apr 19, 2021 16:58 UTC | BED BATH & BEYOND INC BBBY · Entity 117013 | PurchaseCommon Stock, $.01 par value per share | 3,000 | $25.02 | $75,060.00 |
DisclosureSEC source: 0001140361-21-013331 · form4.xml · nonDerivative · entry 1 Schechter Joshua · CIK 0001336601 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,016 Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 17:17 UTC | Pursuit Attractions & Hospitality, Inc. VVI · Entity 4779 | Tax withholdingCommon Stock | 717 | $44.76 | $32,092.92 |
DisclosureSEC source: 0001209191-21-015126 · doc4.xml · nonDerivative · entry 1 Schechter Joshua · CIK 0001336601 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,662 F1 · shares: Shares were surrendered for taxes in connection with vesting of restricted stock granted February 25, 2020. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 19:10 UTC | Pursuit Attractions & Hospitality, Inc. VVI · Entity 4779 | GrantCommon Stock | 2,790 | $44.80 | $124,992.00 |
DisclosureSEC source: 0001209191-21-014249 · doc4.xml · nonDerivative · entry 1 Schechter Joshua · CIK 0001336601 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,379 F1 · shares: Restricted Stock granted on February 23, 2021, pursuant to the 2017 Viad Corp Omnibus Incentive Plan, and will vest one year from the date of grant. Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 17:18 UTC | BED BATH & BEYOND INC BBBY · Entity 117013 | PurchaseCommon Stock, $.01 par value per share | 1,500 | $19.87 | $29,797.50 |
DisclosureSEC source: 0001062993-20-005642 · form4.xml · nonDerivative · entry 1 Schechter Joshua · CIK 0001336601 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,016 Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 17:11 UTC | BED BATH & BEYOND INC BBBY · Entity 117013 | PurchaseCommon Stock, $.01 par value per share | 3,000 | $20.23 | $60,690.00 |
DisclosureSEC source: 0001062993-20-005382 · form4.xml · nonDerivative · entry 1 Schechter Joshua · CIK 0001336601 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,516 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $20.225 to $20.23, inclusive. The reporting person undertakes to provide to Bed Bath & Beyond Inc., any security holder of Bed Bath & Beyond Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this Form 4. Read SEC document |
| October 14, 2020 Filed Oct 16, 2020 21:16 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantRestricted Stock Unit · Derivative | 5,398 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001593968-20-002055 · primary_01.xml · derivative · entry 1 Schechter Joshua · CIK 0001336601 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,398 Underlying: Common Stock · 5,398 shares Expires not disclosed F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · derivative.expiration_date: Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock. Read SEC document |
| September 11, 2020 Filed Sep 15, 2020 22:00 UTC | Support.com, Inc. SPRT · Entity 135472 | GrantCommon Stock | 25,380 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-20-010129 · section16.xml · nonDerivative · entry 1 Schechter Joshua · CIK 0001336601 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,203 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest on the earlier of the first anniversary of the grant date or the date of the Issuer's next Annual Meeting, subject to the Reporting Person's continued service as of such date. Read SEC document |
| August 18, 2020 Filed Aug 18, 2020 20:14 UTC | Pursuit Attractions & Hospitality, Inc. VVI · Entity 4779 | PurchaseCommon Stock | 2,000 | $17.61 | $35,215.00 |
DisclosureSEC source: 0000899243-20-022716 · doc4.xml · nonDerivative · entry 3 Schechter Joshua · CIK 0001336601 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,589 Read SEC document |
| August 18, 2020 Filed Aug 18, 2020 20:14 UTC | Pursuit Attractions & Hospitality, Inc. VVI · Entity 4779 | PurchaseCommon Stock | 1,500 | $17.67 | $26,500.95 |
DisclosureSEC source: 0000899243-20-022716 · doc4.xml · nonDerivative · entry 2 Schechter Joshua · CIK 0001336601 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,589 F1 · price: The price reported in column 4 is the weighted average price. The shares were purchased in two separate transactions ranging from $17.700 to $17.665, inclusive, with the average weighted price being $17.6673. The reporting person undertakes to provide to any security holder of Viad Corp or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| August 14, 2020 Filed Aug 18, 2020 20:14 UTC | Pursuit Attractions & Hospitality, Inc. VVI · Entity 4779 | PurchaseCommon Stock | 3,000 | $18.79 | $56,370.00 |
DisclosureSEC source: 0000899243-20-022716 · doc4.xml · nonDerivative · entry 1 Schechter Joshua · CIK 0001336601 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,089 Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 20:24 UTC | Support.com, Inc. SPRT · Entity 135472 | Exercise / conversionRestricted Stock Units · Derivative | 60,837 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001654954-20-008535 · section16.xml · derivative · entry 2 Schechter Joshua · CIK 0001336601 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 60,837 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") were granted to the Reporting Person on August 1, 2019 under the Issuer's 2010 Equity and Performance Incentive Plan. The RSUs vested in their entirety on August 3, 2020. Upon vesting, each RSU entitled the Reporting Person to one share of the Issuer's common stock. In connection with the Issuer's special dividend distribution on December 26, 2019, the original amount of 31,447 RSUs granted to the Reporting Person was adjusted to 60,837 RSUs. F1 · price: The Restricted Stock Units ("RSUs") were granted to the Reporting Person on August 1, 2019 under the Issuer's 2010 Equity and Performance Incentive Plan. The RSUs vested in their entirety on August 3, 2020. Upon vesting, each RSU entitled the Reporting Person to one share of the Issuer's common stock. In connection with the Issuer's special dividend distribution on December 26, 2019, the original amount of 31,447 RSUs granted to the Reporting Person was adjusted to 60,837 RSUs. F1 · derivative.exercise_date: The Restricted Stock Units ("RSUs") were granted to the Reporting Person on August 1, 2019 under the Issuer's 2010 Equity and Performance Incentive Plan. The RSUs vested in their entirety on August 3, 2020. Upon vesting, each RSU entitled the Reporting Person to one share of the Issuer's common stock. In connection with the Issuer's special dividend distribution on December 26, 2019, the original amount of 31,447 RSUs granted to the Reporting Person was adjusted to 60,837 RSUs. F1 · derivative.expiration_date: The Restricted Stock Units ("RSUs") were granted to the Reporting Person on August 1, 2019 under the Issuer's 2010 Equity and Performance Incentive Plan. The RSUs vested in their entirety on August 3, 2020. Upon vesting, each RSU entitled the Reporting Person to one share of the Issuer's common stock. In connection with the Issuer's special dividend distribution on December 26, 2019, the original amount of 31,447 RSUs granted to the Reporting Person was adjusted to 60,837 RSUs. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 20:24 UTC | Support.com, Inc. SPRT · Entity 135472 | Exercise / conversionCommon Stock | 60,837 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001654954-20-008535 · section16.xml · nonDerivative · entry 1 Schechter Joshua · CIK 0001336601 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,309 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Restricted Stock Units ("RSUs") were granted to the Reporting Person on August 1, 2019 under the Issuer's 2010 Equity and Performance Incentive Plan. The RSUs vested in their entirety on August 3, 2020. Upon vesting, each RSU entitled the Reporting Person to one share of the Issuer's common stock. In connection with the Issuer's special dividend distribution on December 26, 2019, the original amount of 31,447 RSUs granted to the Reporting Person was adjusted to 60,837 RSUs. F1 · price: The Restricted Stock Units ("RSUs") were granted to the Reporting Person on August 1, 2019 under the Issuer's 2010 Equity and Performance Incentive Plan. The RSUs vested in their entirety on August 3, 2020. Upon vesting, each RSU entitled the Reporting Person to one share of the Issuer's common stock. In connection with the Issuer's special dividend distribution on December 26, 2019, the original amount of 31,447 RSUs granted to the Reporting Person was adjusted to 60,837 RSUs. Read SEC document |
| August 03, 2020 Filed Sep 15, 2020 21:54 UTC Amendment | Support.com, Inc. SPRT · Entity 135472 | Exercise / conversionRestricted Stock Unit · Derivative | 60,837 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001654954-20-010127 · section16.xml · derivative · entry 2 Schechter Joshua · CIK 0001336601 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 60,837 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Not applicable. F2 · derivative.expiration_date: Not applicable. Read SEC document |
| August 03, 2020 Filed Sep 15, 2020 21:54 UTC Amendment | Support.com, Inc. SPRT · Entity 135472 | Exercise / conversionCommon Stock | 60,837 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-20-010127 · section16.xml · nonDerivative · entry 1 Schechter Joshua · CIK 0001336601 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,823 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: The amount of securities beneficially owned in Box 5 was amended to 151,823 in this Form 4. Read SEC document |
| July 14, 2020 Filed Jul 15, 2020 18:58 UTC | BED BATH & BEYOND INC BBBY · Entity 117013 | GrantCommon Stock, $.01 par value per share | 8,174 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-20-000632 · edgar.xml · nonDerivative · entry 1 Schechter Joshua · CIK 0001336601 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,516 F1 · shares: Represents a grant of restricted stock under the Company's 2012 Incentive Compensation Plan valued at $81,000, issued as part of annual director compensation and approved by the Board of Directors of the Company on July 14, 2020. The number of shares was determined based on a stock price of $9.91, the average of the high and low trading prices of the Company's common stock on June 8, 2020, the price used to determine the number of shares issued to the Company's senior management team as part of its compensation for the Company's 2020 fiscal year. The restricted stock will vest on February 27, 2021, the last day of the fiscal year of grant, provided that the director remains in office until the last day of the fiscal year. Read SEC document |
| February 25, 2020 Filed Feb 26, 2020 21:58 UTC | Pursuit Attractions & Hospitality, Inc. VVI · Entity 4779 | GrantCommon Stock | 2,223 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-013078 · doc4.xml · nonDerivative · entry 2 Schechter Joshua · CIK 0001336601 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,089 F2 · shares: Restricted Stock granted on February 25, 2020, pursuant to the 2017 Viad Corp Omnibus Incentive Plan, which will vest one year from the date of grant. Read SEC document |
| February 25, 2020 Filed Feb 26, 2020 21:58 UTC | Pursuit Attractions & Hospitality, Inc. VVI · Entity 4779 | PurchaseCommon Stock | 1,000 | $57.98 | $57,977.10 |
DisclosureSEC source: 0001209191-20-013078 · doc4.xml · nonDerivative · entry 1 Schechter Joshua · CIK 0001336601 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,866 F1 · price: The price reported in column 4 is the weighted average price. The shares were purchased in two separate transactions ranging from $57.9912 to $57.963, inclusive, with the average weighted price being $57.9771. The reporting person undertakes to provide to any security holder of Viad Corp or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.